heparin sodium, porcine 5000 UNT/ML Injectable Solution

What the CMS Formulary Data Shows for heparin sodium, porcine 5000 UNT/ML Injectable Solution

Per the CMS 2026 Part D formulary file, heparin sodium, porcine 5000 UNT/ML Injectable Solution (RxNorm concept RXCUI 1361615, generic name heparin sodium, porcine) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 2.3.

Real-world access to heparin sodium, porcine 5000 UNT/ML Injectable Solution depends on utilization management as much as tier placement: 25.2% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 13,864 Part D beneficiaries filled heparin sodium, porcine 5000 UNT/ML Injectable Solution in 2023, with total plan-and-beneficiary spending of $2,796,464 and an average per-beneficiary annual cost of $201.71. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry heparin sodium, porcine 5000 UNT/ML Injectable Solution today.